See All Slides - tctmd.com

Slides

Presentation TCT 2012

BioMime (Meril Life Sciences) Program Update

Presenter: Ashok Seth

October 23, 2012

Presentation TCT 2012

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

Presenter: Peter Brady

October 23, 2012

Presentation TCT 2012

TCT-23. Detection by Near-infrared Spectroscopy of Large Lipid Core Plaques at Culprit Sites in Patients with Acute ST-Segment Elevation Myocardial Infarction

Presenter: Ryan Madder

October 23, 2012

Presentation TCT 2012

Case 3: During an Iliofemoral Intervention

Presenter: D. Christopher Metzger

October 23, 2012

Presentation TCT 2012

TCT-101. 12-month Results of a 2nd Generation Transapical Aortic Bioprosthesis for the Treatment of Patients with Severe Aortic Stenosis

Presenter: Joerg Kempfert

October 23, 2012

Presentation TCT 2012

CorAssist

Presenter: Mitchell Krucoff

October 23, 2012

Presentation TCT 2012

Viability Testing, Clinical Decision Making(2)

Presenter: Issam Mikati

October 23, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: BRIDGE-ACS (Multimodality Approach to Adherence), INFUSE-AMI (STEMI), and IMMEDIATE (GIK)

Presenter: Ajay Kirtane

October 23, 2012

Presentation TCT 2012

Overview: Addressing Structure in Structural Heart Disease

Presenter: Robert Michler

October 23, 2012

Presentation TCT 2012

Synergy (Boston Scientific) Program Update

Presenter: Ian Meredith

October 23, 2012

Advertisement

Slides

BioMime (Meril Life Sciences) Program Update

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

TCT-23. Detection by Near-infrared Spectroscopy of Large Lipid Core Plaques at Culprit Sites in Patients with Acute ST-Segment Elevation Myocardial Infarction

Case 3: During an Iliofemoral Intervention

TCT-101. 12-month Results of a 2nd Generation Transapical Aortic Bioprosthesis for the Treatment of Patients with Severe Aortic Stenosis

CorAssist

Viability Testing, Clinical Decision Making(2)

Late Breaking Clinical Trials: BRIDGE-ACS (Multimodality Approach to Adherence), INFUSE-AMI (STEMI), and IMMEDIATE (GIK)

Overview: Addressing Structure in Structural Heart Disease

Synergy (Boston Scientific) Program Update

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content